Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Glycopeptide, vancomycin analog; peptidoglycan ...
Neuropeptide hormone found in insects, involved...
Endogenous peptide, involved in immune signalin...
Benzamide; HDAC1 inhibitor.
Sulfur analog of furan found in cooked meat pro...
Mixture of glycopeptide bleomycin sulfate salts...
pan-Raf inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
Fibrate; PPARα agonist, enoyl-CoA reductase in...
Purine nucleoside analog; DNA chain terminator....
Non-depolarizing NMJ blocker; nAChR antagonist....
Benzimidazole; microtubule polymerization inhib...
Pyrimidine nucleoside base, pairs with adenosin...
Dihydrofolate reductase inhibitor.
Natriuretic, vasodilatory peptide; B1/2 agonist...
Inhibitor of CDK.
AMPK activator.
Peptide, IgG derivative, tuftsin analog.
Endogenous peptide, involved in vasoconstrictio...
B-Raf inhibitor.